This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Dicerna Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Seongmoon Cheong: Innovator in Oligonucleotide Therapeutics
Introduction
Seongmoon Cheong is a prominent inventor based in Harvard, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic oligonucleotides. His work focuses on innovative methods to modulate biological activities that are crucial for treating various diseases.
Latest Patents
Seongmoon Cheong holds a patent for "Compositions and methods for modulating activity." This patent discloses oligonucleotides and compositions that modulate the activity of sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP). The methods outlined in the patent are particularly relevant for treating conditions associated with SCAP activity, such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), dyslipidemia, and atherosclerotic cardiovascular disease (ASCVD). He has 1 patent to his name.
Career Highlights
Seongmoon Cheong is currently associated with Dicerna Pharmaceuticals, Inc., where he continues to advance his research in oligonucleotide therapeutics. His work is instrumental in developing innovative treatments that target complex diseases.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Seongmoon Cheong's contributions to the field of biotechnology through his innovative patent work exemplify the potential of oligonucleotides in treating serious health conditions. His ongoing research at Dicerna Pharmaceuticals, Inc. continues to pave the way for future advancements in therapeutic applications.